National Institute of Dental & Craniofacial Research; Notice of Closed Meeting, 58409-58410 [2010-23949]

Download as PDF srobinson on DSKHWCL6B1PROD with NOTICES Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices but for whom it is not feasible to estimate their radiation dose, and on whether there is a reasonable likelihood that such radiation doses may have endangered the health of members of this class. The Subcommittee on Procedures Review was established to aid the ABRWH in carrying out its duty to advise the Secretary, HHS, on dose reconstructions. The Subcommittee on Procedures Review is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor. Matters To Be Discussed: The agenda for the Subcommittee meeting includes: Review of draft prototype documents for informing the public on completed Subcommittee procedure reviews; discussion of the following ORAU & OCAS procedures: PER–012 (‘‘Evaluation of Highly Insoluble Plutonium Compounds’’), PER–009 (‘‘Target Organs for Lymphoma’’), OCAS TIB–0013 (‘‘Special External Dose Reconstruction Considerations for Mallinckrodt Workers’’), OTIB–014 (‘‘Rocky Flats Internal Dosimetry CoWorker Extension’’), OTIB–019 (‘‘Analysis of Co-worker Bioassay Data for Internal Dose Assignment’’), OTIB– 0029 (‘‘Internal Dosimetry Co-worker Data for Y–12’’), OTIB–0049 (‘‘Estimating Doses for Plutonium Strongly Retained in the Lung’’), OTIB– 0047 (External Radiation Monitoring at the Y–12 Facility During the 1948–1949 Period’’), OTIB–0051 (‘‘Effect of Threshold Energy and Angular Response of NTA Film on Missed Neutron Dose at the Oak Ridge Y–12 Facility’’), OTIB–0052 (‘‘Parameters to Consider When Processing Claims for Construction Trade Workers’’), OTIB– 0054 (‘‘Fission and Activation Product Assignment for Internal Dose-Related Gross Beta and Gross Gamma Analyses’’), OTIB–0057 (‘‘External Radiation Dose Estimates For Individuals Near the 1958 Criticality Accident at the Oak Ridge Y–12 Plant’’), OTIB–0070 (‘‘Dose Reconstruction During Residual Radioactivity Periods at Atomic Weapons Employer Facilities’’), and TBD 6000 (‘‘Site Profile for Atomic Weapons Employers that Worked Uranium and Thorium Metals’’); and a continuation of the comment-resolution process for other dose reconstruction procedures under review by the Subcommittee. The agenda is subject to change as priorities dictate. This meeting is open to the public, but without a public comment period. In the event an individual wishes to VerDate Mar<15>2010 16:12 Sep 23, 2010 Jkt 220001 provide comments, written comments may be submitted. Any written comments received will be provided at the meeting and should be submitted to the contact person below in advance of the meeting. Contact Person for More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E–20, Atlanta, Georgia 30333, Telephone (513) 533–6800, Toll Free 1 (800) CDC–INFO, E-mail dcas@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: September 17, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. 58409 Blvd., Rm. 676, Bethesda, MD 20892–4878, 301–594–4861, mooremar@nidcr.nih.gov. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; RFA DE–11–001 Collaborative Research on the Transition From Acute to Chronic Pain: New Models and Measures in Clinical and Preclinical Pain Research (R01). Date: October 28, 2010. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Hotel—Silver Spring, 8777 Georgia Avenue, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Victor Henriquez, PhD, Scientific Review Officer, DEA/SRB/NIDCR, 6701 Democracy Blvd., Room 668, Bethesda, MD 20892–4878, 301–451–2405, henriquv@nidcr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) [FR Doc. 2010–24006 Filed 9–23–10; 8:45 am] Dated: September 20, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. BILLING CODE 4163–18–P [FR Doc. 2010–23951 Filed 9–23–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Dental & Craniofacial Research; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Scientific Review of P01 Applications submitted to PAR 08–117. Date: October 20, 2010. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Marilyn Moore-Hoon, PhD, Scientific Review Officer, Scientific Review Branch, National Institute of Dental and Craniofacial Research, 6701 Democracy PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 National Institute of Dental & Craniofacial Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review F30s, R03. Date: October 18, 2010. Time: 2:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Mary Kelly, Scientific Review Officer, Scientific Review Branch, E:\FR\FM\24SEN1.SGM 24SEN1 58410 Federal Register / Vol. 75, No. 185 / Friday, September 24, 2010 / Notices National Inst of Dental & Craniofacial Research, NIH 6701 Democracy Blvd, room 672, MSC 4878, Bethesda, md 20892–4878, 301–594–4809, mary_kelly@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: September 16, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the meeting of the National Science Advisory Board for Biosecurity (NSABB). [FR Doc. 2010–23949 Filed 9–23–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting srobinson on DSKHWCL6B1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Allergy, Immunology, and Transplantation Research Committee. Date: October 20, 2010. Time: 10 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817. Contact Person: Zhuqing Li, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, DHHS/NIH/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892–7616, 301– 402–9523, zhuqing.li@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: September 20, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–23948 Filed 9–23–10; 8:45 am] BILLING CODE 4140–01–P VerDate Mar<15>2010 16:12 Sep 23, 2010 Jkt 220001 National Institutes of Health Office of Biotechnology Activities, Office of Science Policy, Office of the Director; Notice of Meeting Name of Committee: National Science Advisory Board for Biosecurity. Date: October 19, 2010. Time: 8:30 a.m. to 4 p.m. Eastern Daylight Time (Times are approximate and subject to change). Agenda: Presentations and discussions regarding: (1) Update of Federal activities relevant to the mission of the NSABB; (2) activities of NSABB Working Groups on Codes of Conduct; Culture of Responsibility; International Engagement; Journal Review Policies; and Outreach and Education; (3) consideration of advances in synthetic biology in relation to NSABB recommendations regarding biosecurity concerns raised by this field; (4) planning for future NSABB meetings and activities; and (5) other business of the Board. Place: National Institutes of Health, Building 31, Center Drive, C–Wing, 6th Floor, Conference Room 10, Bethesda, Maryland 20892. Contact Person: Ronna Hill, NSABB Program Assistant, NIH Office of Biotechnology Activities, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892, (301) 496–9838, hillro@od.nih.gov. Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established the NSABB to provide advice, guidance and leadership regarding federal oversight of dual use research, defined as biological research that generates information and technologies that could be misused to pose a biological threat to public health and/or national security. The meeting will be open to the public, however pre-registration is strongly recommended due to space limitations. Persons planning to attend should register online at: https://oba.od.nih.gov/biosecurity/ biosecurity_meetings.html or by calling Palladian Partners, Inc. (Contact: Joel Yaccarino at 301–650–8660.) Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate these requirements upon registration. This meeting will also be webcast. To access the webcast, as well as the draft meeting agenda and pre-registration information, connect to: https:// oba.od.nih.gov/biosecurity/ biosecurity_meetings.html. Please check this site for updates. Any member of the public interested in presenting oral comments relevant to the PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 mission of the NSABB at the meeting may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of an organization may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments relevant to the mission of the NSABB. All written comments must be received by October 12, 2010 and should be sent via e-mail to nsabb@od.nih.gov with ‘‘NSABB Public Comment’’ as the subject line or by regular mail to 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, Attention: Ronna Hill. The statement should include the name, address, telephone number and, when applicable, the business or professional affiliation of the interested person. Dated: September 20, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–23947 Filed 9–23–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Eye Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Eye Institute Special Emphasis Panel; NIH Joint Neuroscience T32 Training Program. Date: October 25, 2010. Time: 8:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Anne E. Schaffner, PhD, Scientific Review Officer, Division of Extramural Research, National Eye Institute, National Institutes of Health, 5635 Fishers Lane, Suite 1300, MSC 9300, 301–451–2020, aes@nei.nih.gov. E:\FR\FM\24SEN1.SGM 24SEN1

Agencies

[Federal Register Volume 75, Number 185 (Friday, September 24, 2010)]
[Notices]
[Pages 58409-58410]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-23949]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Dental & Craniofacial Research; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Emphasis Panel; Review F30s, R03.
    Date: October 18, 2010.
    Time: 2:30 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, One Democracy Plaza, 6701 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Mary Kelly, Scientific Review Officer, 
Scientific Review Branch,

[[Page 58410]]

National Inst of Dental & Craniofacial Research, NIH 6701 Democracy 
Blvd, room 672, MSC 4878, Bethesda, md 20892-4878, 301-594-4809, 
mary_kelly@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral 
Diseases and Disorders Research, National Institutes of Health, HHS)

    Dated: September 16, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-23949 Filed 9-23-10; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.